| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
What is the Efficacy of Multivitamin-Multimineral Supplements in Chronic Disease Prevention in the General Population of Adults? |
1 From the Division of Cancer Prevention (PG) and the Division of Cancer Epidemiology and Genetics (PRT), National Cancer Institute, National Institutes of Health, Bethesda, MD, and The Scientific Consulting Group, Inc, Gaithersburg, MD (DA and SAN)
ABSTRACT
Approximately 20–30% of Americans consume multivitamin supplements daily, indicating high public interest in the prevention of cancer and other chronic diseases through a nutrition-based approach. Although several bioactive food components, including vitamins and minerals, have been investigated for their ability to affect cancer risk, few large, randomized, placebo-controlled clinical trials of multivitamins with cancer as the primary endpoint have been performed. The results of most large-scale trials of multivitamin supplements (combinations of 
2 vitamins and minerals) to prevent cancer have been mixed. The Linxian General Population and Dysplasia trials found a decreased risk of cancer, particularly stomach cancer, for participants taking a multivitamin supplement, but this was in a borderline-deficient population in China. Two trials, the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study and the β-Carotene and Retinol Efficacy Trial, found an increased risk of lung cancer among male cigarette smokers or asbestos-exposed persons taking β-carotene—a surprising result, considering that most epidemiologic studies have suggested that consumption of fruit and vegetables appears to lower cancer risk. To clarify the effects of multivitamin supplements, several large randomized clinical trials are underway, including the Physicians' Health Study II, the Selenium and Vitamin E Cancer Prevention Trial, and a European study, Supplémentation en Vitamines et Minéraux Antioxydants (SU.VI. MAX). Because epidemiologic studies generally evaluate foods rather than specific bioactive food components, a systematic approach to determining how combinations of vitamins and minerals may interact to ameliorate cancer risk is necessary to further our understanding of the potential benefits and risks of supplement use.
Key Words: Multivitamin supplements • randomized clinical trials • cancer prevention • bioactive food components • nutrition
This article has been cited by other articles:
|
|
 |
|
  P. J. Goodwin, M. Ennis, K. I. Pritchard, J. Koo, and N. Hood Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer J. Clin. Oncol., August 10, 2009; 27(23): 3757 - 3763. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Goodwin Vitamin D in Cancer Patients: Above All, Do No Harm J. Clin. Oncol., May 1, 2009; 27(13): 2117 - 2119. [Full Text] [PDF]
|
|
|
|
 |
|
 D. R Jacobs Jr, M. D Gross, and L. C Tapsell Food synergy: an operational concept for understanding nutrition Am. J. Clinical Nutrition, May 1, 2009; 89(5): 1543S - 1548S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Satia, A. Littman, C. G. Slatore, J. A. Galanko, and E. White Long-term Use of {beta}-Carotene, Retinol, Lycopene, and Lutein Supplements and Lung Cancer Risk: Results From the VITamins And Lifestyle (VITAL) Study Am. J. Epidemiol., April 1, 2009; 169(7): 815 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. C. Freedman and P. J. Goodwin The Role of Vitamin D in Breast Cancer Recurrence ASCO Educational Book, January 1, 2009; 2009(1): 79 - 83. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
